Samela PC, Tosi V, Cervini AB, Bocian M, Buján MM, Pierini AM. Nevoid basal cell carcinoma syndrome: our experience in a pediatric hospital.
ACTAS DERMO-SIFILIOGRAFICAS 2013;
104:426-33. [PMID:
23669591 DOI:
10.1016/j.adengl.2013.04.006]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2011] [Accepted: 04/20/2012] [Indexed: 10/26/2022] Open
Abstract
Nevoid basal cell carcinoma (BCC) syndrome, or Gorlin syndrome, is a rare autosomal dominant disorder associated with mutations in the patched 1 gene, PTCH1. It is characterized by the presence of multiple BCCs in association with disorders affecting the bones, the skin, the eyes, and the nervous system. We describe 6 cases of nevoid BCC syndrome evaluated in our department. Palmoplantar pitting was observed in all 6 patients, multiple BCCs in 5 patients (83%), skeletal anomalies in 3 patients (50%), and odontogenic keratocysts in 1 patient (17%). We would like to stress the importance of early diagnosis and treatment in nevoid BCC syndrome and the need for continuous, long-term follow-up by a multidisciplinary team.
Collapse